Attention deficit hyperactivity disorder in adults

References

• Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D. 2005. Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry 66(3):294–299.
   PubMed Web of Science ®Google Scholar
• Adler L, Dietrich A, Reimherr FW, Taylor LV, Sutton VK, Bakken R, . 2006a. Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD. Ann Clin Psychiatry 18(2):107–113.
   PubMedGoogle Scholar
• Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, . 2006b. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. J Clin Psychopharmacol 26(6):648–652.
   PubMed Web of Science ®Google Scholar
• Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, . 2008a. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69(9):1364–1373.
   PubMed Web of Science ®Google Scholar
• Adler LA, Spencer T, McGough JJ, Jain H, Muniz R. 2008b. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Attent Disord 12(5):449–459
   Web of Science ®Google Scholar
• American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text revision. Arlington, VA: American Psychiatric Association Publishing Inc.
   Google Scholar
• American Psychiatric Association. 2010. DSM-5: Options being considered for ADHD. Available at: http://www.dsm5.org/Proposed%20Revision%20Attachments/APA%20Options%20for%20ADHD.pdf (accessed 30 March 2010).
   Google Scholar
• Asherson P, Chen W, Craddock B, Taylor E. 2007. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 190:4–5.
   PubMed Web of Science ®Google Scholar
• Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, . 2006. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15(8):476–495.
   PubMed Web of Science ®Google Scholar
• Bangs ME, Jin L, Zhang S, Desaiah D, Allen AJ, Read HA, . 2008. Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder. Drug Saf 31(4):345–354.
   PubMed Web of Science ®Google Scholar
• Barkley R, Murphy K, Fischer M. 2007a. ADHD in adults: What the science says. New York: Guilford Press.
   Google Scholar
• Barkley RA, Anderson DL, Kruesi M. 2007b. A pilot study of the effects of atomoxetine on driving performance in adults with ADHD. J Atten Disord 10(3):306–316.
   PubMedGoogle Scholar
• Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366(9481):237–248.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV. 2006. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed 8(3):12.
   PubMedGoogle Scholar
• Biederman J, Spencer TJ, Wilens TE, Weisler RH, Read SC, Tulloch SJ. 2005. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 10(12 Suppl 20):16–25.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. 2006a. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 67(4):524–540.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, . 2006b. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 59(9):829–835.
   PubMed Web of Science ®Google Scholar
• Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. 2005. Executive functioning in adult ADHD: a meta-analytic review. Psychol Med 35(8):1097–1108.
   PubMed Web of Science ®Google Scholar
• Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK, Van Someren EJ. 2007. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 30(4):433–442.
   PubMed Web of Science ®Google Scholar
• Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, . 1999. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 45(12):1542–1552.
   PubMed Web of Science ®Google Scholar
• Bush G, Valera EM, Seidman LJ. 2005. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry 57(11):1273–1284.
   PubMed Web of Science ®Google Scholar
• Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. 2004. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 43(3):269–275.
   PubMed Web of Science ®Google Scholar
• de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, . 2008. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 65(12):835–842.
   PubMed Web of Science ®Google Scholar
• Dulcan M. 1997. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36(10 Suppl):85–121S.
   PubMed Web of Science ®Google Scholar
• Eakin L, Minde K, Hechtman L, Ochs E, Krane E, Bouffard R, . 2004. The marital and family functioning of adults with ADHD and their spouses. J Atten Disord 8(1):1–10.
   PubMedGoogle Scholar
• Ehlis AC, Bahne CG, Jacob CP, Herrmann MJ, Fallgatter AJ. 2008. Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res 42(13):1060–1067.
   PubMed Web of Science ®Google Scholar
• Ellison-Wright I, Ellison-Wright Z, Bullmore E. 2008. Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis. BMC Psychiatry 8:51.
   PubMed Web of Science ®Google Scholar
• Faraone SV. 2008. Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder. Expert Opin Pharmacother 9(9):1565–1574.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. 2004. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24(1):24–29.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Doyle A, Murray K, Petty C, Adamson JJ, . 2006a. Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry 60(10):1081–1087.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, . 2006b. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 163(10):1720–1729; quiz 1859.
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, . 2007. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409.
   PubMed Web of Science ®Google Scholar
• Fayed N, Modrego PJ, Castillo J, Davila J. 2007. Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol 14(9):1029–1035.
   PubMed Web of Science ®Google Scholar
• Fischer M, Barkley RA, Smallish L, Fletcher K. 2007. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes. Accid Anal Prev 39(1):94–105.
   PubMed Web of Science ®Google Scholar
• Fried R, Petty CR, Surman CB, Reimer B, Aleardi M, Martin JM, . 2006. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: A controlled study. J Clin Psychiatry 67(4):567–574.
   PubMed Web of Science ®Google Scholar
• Gau SS, Kessler RC, Tseng WL, Wu YY, Chiu YN, Yeh CB, . 2007. Association between sleep problems and symptoms of attention-deficit/hyperactivity disorder in young adults. Sleep 30(2):195–201.
   PubMed Web of Science ®Google Scholar
• Gibbins C, Weiss M. 2007. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep 9(5):420–426.
   PubMedGoogle Scholar
• Goodman DW, Ginsberg L, Weisler RH, Cutler AJ, Hodgkins P. 2005. An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 10(12 Suppl 20):26–34.
   PubMed Web of Science ®Google Scholar
• Harvey E, Danforth JS, McKee TE, Ulaszek WR, Friedman JL. 2003. Parenting of children with attention-defecit/hyperactivity disorder (ADHD): the role of parental ADHD symptomatology. J Atten Disord 7(1):31–42.
   PubMedGoogle Scholar
• Hervey AS, Epstein JN, Curry JF. 2004. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology 18(3):485–503.
   PubMed Web of Science ®Google Scholar
• Hesslinger B, Tebartz van Elst L, Nyberg E, Dykierek P, Richter H, Berner M, . 2002. Psychotherapy of attention deficit hyperactivity disorder in adults–a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 252(4):177–184.
   PubMed Web of Science ®Google Scholar
• Jain N, Hechtman L, Quinn D. 2006. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA): Canadian ADHD Clinical Practice Guidelines. Toronto: CADDRA.
   Google Scholar
• Kemner JE, Lage MJ. 2006. Effect of methylphenidate formulation on treatment patterns and use of emergency room services. Am J Health Syst Pharm 63(4):317–322.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, . 2005. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 47(6):565–572.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, . 2006. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723.
   PubMed Web of Science ®Google Scholar
• Kooij JJ, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. 2004. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 34(6):973–782.
   PubMed Web of Science ®Google Scholar
• Kooij SJJ, Boonstra KA, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK. 2008. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord 11(4): 445–458.
   PubMed Web of Science ®Google Scholar
• Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, . 2001. Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 13(3):129–134.
   PubMedGoogle Scholar
• Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, . 2007. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex 17(6):1364–1375.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Barkley RA. 2004. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 161(11):1948–1956.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, . 2005. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 162(9):1621–1627.
   PubMed Web of Science ®Google Scholar
• Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemela A, Trott GE, . 2008. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 63(10):981–989.
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, . 2003. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53(2): 112–120.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, . 2005. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 57(11):1467–1473.
   PubMed Web of Science ®Google Scholar
• National Institute for Mental Health. 2009. Attention Deficit Hyperactivity Disorder. Available at: http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/complete-index.shtml (accessed August 2009).
   Google Scholar
• National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder. Diagnosis and management of ADHD in children, young people and adults. September 2008
   Google Scholar
• Newcorn JH. 2008. Cardiovascular safety of ADHD medication treatments. CNS Spectr 13(Suppl 15):5–8.
   PubMedGoogle Scholar
• Nissen SE. 2006. ADHD drugs and cardiovascular risk. New Engl J Med 354(14):1445–1448.
   PubMed Web of Science ®Google Scholar
• Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, . 2007. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21(1):10–41.
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC, Zhang HF, Wan GJ. 2007. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm 13(7):570–577.
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gomez N, . 2008. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 22(7):603–611.
   PubMed Web of Science ®Google Scholar
• Reimer B, D'Ambrosio LA, Coughlin JF, Fried R, Biederman J. 2007. Task-induced fatigue and collisions in adult drivers with attention deficit hyperactivity disorder. Traffic Inj Prev 8(3):290–299.
   PubMedGoogle Scholar
• Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, . 2005. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry 58(2): 125–131.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. 2007. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 68(1):93–101.
   PubMed Web of Science ®Google Scholar
• Ribases M, Hervas A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, . 2008. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 63(10):935–945.
   PubMed Web of Science ®Google Scholar
• Richards TL, Deffenbacher JL, Rosen LA, Barkley RA, Rodricks T. 2006. Driving anger and driving behavior in adults with ADHD. J Atten Disord 10(1):54–64.
   PubMedGoogle Scholar
• Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, . 2004. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 254(6):365–371.
   PubMed Web of Science ®Google Scholar
• Rösler M, Fischer R, Ammer R, Ose C, Retz W. 2009. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 259(2):120–129.
   PubMed Web of Science ®Google Scholar
• Safren SA, Sprich S, Chulvick S, Otto MW. 2004. Psychosocial treatments for adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 27(2):349–360.
   PubMed Web of Science ®Google Scholar
• Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. 2005. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 43(7):831–842.
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, . 2006. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry 60(10):1071–1080.
   PubMed Web of Science ®Google Scholar
• Sobanski E, Schredl M, Kettler N, Alm B. 2008. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 31(3):375–381.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, . 2005. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57(5):456–463.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, . 2007a. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry 62(9):1059–1061.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L. 2007b. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 61(12):1380–1387.
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Whitmont S, Bornholt L, Livesey D, Stevenson RJ. 2002. A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust NZ J Psychiatry 36(5):610–616.
   PubMed Web of Science ®Google Scholar
• Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, et al. 2003. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 60(2):204–211.
   PubMed Web of Science ®Google Scholar
• Verster JC, Bekker EM, de Roos M, Minova A, Eijken EJ, Kooij JJ, . 2008. Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. J Psychopharmacol 22(3): 230–237.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, . 2007. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64(8):932–940.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, Wilens TE. 2005. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 10(12 Suppl 20):35–43.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, . 2006. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 11(8):625–639.
   PubMed Web of Science ®Google Scholar
• Wender EH. 1995. Attention-deficit hyperactivity disorders in adolescence. J Dev Behav Pediatr 16(3):192–195.
   PubMed Web of Science ®Google Scholar
• Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, et al. 2003. Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 26(10):729–740.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, . 2005. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 66(2):253–259.
   PubMed Web of Science ®Google Scholar
• Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. 2005. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57(11):1336–1346.
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Doffing MA. 2004. Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs 18(4):243–250.
   PubMed Web of Science ®Google Scholar